发明名称 |
COMBINATION THERAPY FOR TREATMENT OF OBESITY AND DIABETES AND CONDITION RELATED THERETO AND FOR TREATMENT OF CONDITION AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a composition for treating or preventing diabetes or a condition related thereto comprising a therapeutically effective amount of a BRS-3 agonist and a DPP-IV inhibitor. <P>SOLUTION: The invention concerns combination of an amount of a BRS-3 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the BRS-3 agonist alone and by the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing obesity and diabetes and conditions related thereto and conditions ameliorated by increasing a blood GLP-1 level. The invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2012136554(A) |
申请公布日期 |
2012.07.19 |
申请号 |
JP20120090364 |
申请日期 |
2012.04.11 |
申请人 |
ARENA PHARMACEUTICALS INC |
发明人 |
CHU ZHI-LIANG;LEONARD JAMES N |
分类号 |
A61K45/06;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/48;A61P5/50;A61P9/00;A61P9/10;A61P9/12;A61P13/12;A61P21/00;A61P25/00;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/12;A61P43/00;C12N15/09 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|